Cargando…

The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL

SIMPLE SUMMARY: T-prolymphocytic leukemia (T-PLL) is a rare and poor-prognostic mature T-cell leukemia. A better understanding of this chemotherapy-refractory disease is highly warranted to identify novel treatment strategies. We previously identified an elevated expression of the miR-141/200c clust...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otte, Moritz, Stachelscheid, Johanna, Glaß, Markus, Wahnschaffe, Linus, Jiang, Qu, Lone, Waseem, Ianevski, Aleksandr, Aittokallio, Tero, Iqbal, Javeed, Hallek, Michael, Hüttelmaier, Stefan, Schrader, Alexandra, Braun, Till, Herling, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177500/ https://www.ncbi.nlm.nih.gov/pubmed/37173993 http://dx.doi.org/10.3390/cancers15092527

Ejemplares similares

Advances and Perspectives in the Treatment of T-PLL
por: Braun, Till, et al.
Publicado: (2020)

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
por: Wahnschaffe, Linus, et al.
Publicado: (2019)

Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathways
por: Braun, Till, et al.
Publicado: (2020)

The dawn of a new era in treating T-PLL
por: Schrader, Alexandra, et al.
Publicado: (2019)

SynergyFinder 2.0: visual analytics of multi-drug combination synergies
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

Hijacking the Pathway: Perspectives in the Treatment of Mature T-cell Leukemias
por: Wahnschaffe, Linus, et al.
Publicado: (2021)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2017)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
por: Schrader, A., et al.
Publicado: (2018)

P1228: GENOME-WIDE CRISPR-CAS9 SCREENING IDENTIFIES THERAPEUTIC TARGETS FOR MATURE T-CELL MALIGNANCIES
por: Timonen, Sanna, et al.
Publicado: (2023)

Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia
por: Mikhaylenko, Nathan, et al.
Publicado: (2022)

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data
por: Potdar, Swapnil, et al.
Publicado: (2023)

The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis
por: Liu, Lulu, et al.
Publicado: (2018)

Lo et lo control: PLL x 2 OU PLL x 1
por: Barthélemy, R, et al.
Publicado: (1992)

PLL performance: simulation and design
por: Banerjee, Dean
Publicado: (2006)

An Improved PLL for Tune Measurements
por: Berrig, O
Publicado: (2003)

Breeze: an integrated quality control and data analysis application for high-throughput drug screening
por: Potdar, Swapnil, et al.
Publicado: (2020)

Polynomial Method for PLL Controller Optimization
por: Wang, Ta-Chung, et al.
Publicado: (2011)

CMOS PLL Synthesizers: Analysis and Design
por: Shu, Keliu, et al.
Publicado: (2005)

CMS Tracker PLL Reference Manual
por: Moreira, P, et al.
Publicado: (2000)

The process of leukemogenesis.
por: Irons, R D, et al.
Publicado: (1996)

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Braun, Till, et al.
Publicado: (2021)

The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
por: Stachelscheid, Johanna, et al.
Publicado: (2021)

Digital PLL frequency synthesizers: theory and design
por: Rohde, Ulrich L
Publicado: (1983)

Improvement of PLL algorithm for the LEP Q-meter
por: Berrig, O E
Publicado: (1998)

The Philadelphia chromosome in leukemogenesis
por: Kang, Zhi-Jie, et al.
Publicado: (2016)

CELLULAR LOCALIZATION OF ANTI-DNP-PLL AND ANTICONVEYOR ALBUMIN ANTIBODIES IN GENETIC NONRESPONDER GUINEA PIGS IMMUNIZED WITH DNP-PLL ALBUMIN COMPLEXES
por: Green, Ira, et al.
Publicado: (1967)

Case Report: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations
por: Pflug, Natali, et al.
Publicado: (2022)

Regulation of miR‐200c and miR‐141 by Methylation in Prostate Cancer
por: Lynch, Seodhna M., et al.
Publicado: (2016)

PLL Usage in the General Machine Timing System for the LHC
por: Alvarez-Sanchez, P, et al.
Publicado: (2003)

Leukemogenesis and ageing: ‘fit for transformation’ ?
por: Greaves, Mel
Publicado: (2011)

Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
por: White, Judith M., et al.
Publicado: (2021)

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
por: Antolín, Silvia, et al.
Publicado: (2015)

The lpGBT PLL and CDR Architecture, Performance and SEE Robustness
por: Biereigel, Stefan, et al.
Publicado: (2020)

General-Purpose PLL: - PS - RF - LL pour AD -
por: Provost, Jean, et al.
Publicado: (1998)

Cooperation of p300 and PCAF in the Control of MicroRNA 200c/141 Transcription and Epithelial Characteristics
por: Mizuguchi, Yoshiaki, et al.
Publicado: (2012)

Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through
por: Batista, Luciana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7oed367qlmmmjg96lijnume1sr